For example, treatment of RT2 mice with anti-angiogenic drugs, sunitinib or VEGFR2 inhibitor, causes temporary tumor regression followed by evasive drug resistance marked by increased invasiveness and malignancy. The gene discussed is KDR; the disease is neoplasm.